PRND and ovarian cancer: To confirm the involvement of Doppel in promoting EMT in the ascites TME, we treated SK‐OV‐3 cells, an ascites‐derived ovarian cancer cell line, with a Doppel‐high and Doppel‐low concentration for 24 hours.